Clinical trial
Phase II Study of RR110 in Patients With Active Crohn's Disease
NCT00417391 · R&R Inc., Industry · Completed
Key facts
| NCT number | NCT00417391 |
|---|---|
| Title | Phase II Study of RR110 in Patients With Active Crohn's Disease |
| Official title | Phase II Study of RR110 in Patients With Active Crohn's Disease |
| Lead sponsor | R&R Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | RR110 (Tamibarotene) |
| Enrollment | 24 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 1, 2007 |
| Last update posted | May 29, 2008 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: